MASIMO CORP. FILES 8-K ON FINANCIAL RESULTS & REG FD DISCLOSURE

Ticker: MASI · Form: 8-K · Filed: Jan 10, 2024 · CIK: 937556

Masimo CORP 8-K Filing Summary
FieldDetail
CompanyMasimo CORP (MASI)
Form Type8-K
Filed DateJan 10, 2024
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: financial-results, regulation-fd, corporate-filing

TL;DR

**Masimo just dropped an 8-K with fresh financial results and disclosures, so get ready for new data.**

AI Summary

Masimo Corp. filed an 8-K on January 10, 2024, primarily to report on its results of operations and financial condition, along with Regulation FD Disclosure and Financial Statements and Exhibits. This filing indicates that Masimo is providing updated financial information, which is crucial for investors to understand the company's current performance and future outlook. For shareholders, this means new data is available to assess the health and trajectory of their investment.

Why It Matters

This filing provides investors with the latest financial health and operational updates for Masimo Corp., enabling them to make informed decisions about buying, holding, or selling the stock.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information and does not inherently signal a high-risk event.

Analyst Insight

A smart investor would review the detailed financial statements and disclosures that accompany this 8-K to understand Masimo Corp.'s current performance and any forward-looking statements, as this filing itself is a notification of such information.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Masimo Corp. on January 10, 2024?

The primary purpose of this 8-K filing by Masimo Corp. on January 10, 2024, is to report on 'Results of Operations and Financial Condition', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits' as per the 'ITEM INFORMATION' section.

What is the trading symbol and the exchange where Masimo Corp.'s common stock is registered?

Masimo Corp.'s common stock, with a $0.001 par value, trades under the symbol 'MASI' and is registered on 'The Nasdaq Stock Market LLC', as stated in the 'Securities Registered pursuant to Section 12(b) of the Act' section.

What is Masimo Corp.'s business address and phone number?

Masimo Corp.'s business address is '52 Discovery Irvine, CA 92618' and its telephone number is '(949) 297-7000', according to the 'BUSINESS ADDRESS' and 'BUSINESS PHONE' sections of the filing.

What is the state of incorporation for Masimo Corp.?

Masimo Corp. is incorporated in 'DE' (Delaware), as indicated under 'State or other jurisdiction of incorporation' in the filing.

Is Masimo Corp. considered an emerging growth company according to this filing?

No, the filing indicates that Masimo Corp. is not an emerging growth company, as the checkbox for 'Emerging growth company' is not marked.

Filing Stats: 818 words · 3 min read · ~3 pages · Grade level 12.2 · Accepted 2024-01-10 08:11:36

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On January 10, 2024, Masimo Corporation (the "Company") issued a press release announcing select preliminary financial results for the fourth quarter and full-year ended December 30, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report. The preliminary financial information presented in this press release is based on the Company's current expectations and may be adjusted as a result of, among other things, completion of customary annual audit procedures. The Company's management plans to discuss the Company's complete fourth quarter and full-year 2023 financial results after the market closes on Tuesday, February 27, 2024. In accordance with General Instructions B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. In connection with the Company's participation at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024, the Company's Chief Financial Officer, will review select preliminary financial results for the fourth quarter and full-year 2023 and estimates for its full-year 2024 financial guidance. In addition, the Company is making available to investors supplemental financial information for fiscal 2017, 2018, 2019, 2020, 2021, 2022 and the first, second and third quarter of fiscal 2022 and 2023 pursuant to the materials furnished as Exhibit 99.2 to this Current Report, as well as a discussion of non-GAAP measures, adjustments and definitions pursuant to the materials furnished as Exhibit 99.3 to this Current Report. In accordance with General Instructions B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) The following items are filed as exhibits to the Current Report on Form 8-K. Exhibit No. Description 99.1 Press Release, Dated January 10, 2024, Reporting Select Preliminary 2023 Financial Results and 2024 Guidance 99.2 Masimo Fourth Quarter 202 3 Supplemental Earnings Presentation 99.3 Masimo GAAP to Non-GAAP Definitions 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Masimo Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MASIMO CORPORATION Date: January 10, 2024 By: /s/ M ICAH Y OUNG Micah Young Executive Vice President & Chief Financial Officer (Principal Financial Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing